Localized Renal Cell Carcinoma
Localized Renal Cell Carcinoma
Advertisement
Zachary BessetteLocalized Renal Cell Carcinoma | January 20, 2023
A new study evaluated renal function outcomes for patients with oncocytoma managed with surveillance vs nephrectomy.
Read More
Zachary BessetteLocalized Renal Cell Carcinoma | December 20, 2022
Guadecitabine may be well tolerated in patients with dSDH tumors, including HLRCC-RCC, according to results of a new study.
Leah LawrenceLocalized Renal Cell Carcinoma | December 7, 2022
Cryoablation and heat-based thermal ablation represent alternative management options for frail and/or comorbid RCC patients.
Akhil Abraham Saji, MDJournal | November 22, 2022
Stereotactic body radiotherapy can benefit RCC patients deemed unfit for surgical therapy.
Leah LawrenceLocalized Renal Cell Carcinoma | October 18, 2022
Checkmate 914 assigned patients to nivolumab plus ipilimumab or placebo and found no difference in disease-free survival.
GU Oncology Now EditorsSUO Annual Meeting 2021 | December 2, 2021
Researchers evaluated the new AUA risk stratification system for survival in patients with clear cell or papillary RCC.
GU Oncology Now EditorsAUA 2021 | September 13, 2021
There is little to no clinical value in surveillance of pulmonary recurrence following resection of T1a renal cell carcinoma.
Advertisement
Advertisement
Advertisement